{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:00:00Z","timestamp":1791547200811,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jdiacomp.2021.108015","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T03:12:07Z","timestamp":1628046727000},"page":"108015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Skin autofluorescence is associated with higher risk of cardiovascular events in Chinese adults with type 2 diabetes: A prospective cohort study from the Hong Kong Diabetes Biobank"],"prefix":"10.1016","volume":"35","author":[{"given":"Qiao","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.H.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea O.Y.","family":"Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine Y.K.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kit-man","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cadmon K.P.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice P.S.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia J.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana C.N.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.W.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2021.108015_bb0005","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","article-title":"Mortality and cardiovascular disease in type 1 and type 2 diabetes","volume":"376","author":"Rawshani","year":"2017","journal-title":"New Engl J Med."},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2337\/dci17-0052","article-title":"Heart failure: the most important, preventable, and treatable cardiovascular complication of type 2 diabetes","volume":"41","author":"Packer","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0015","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/cs1010671","article-title":"The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)","volume":"101","author":"Stevens","year":"2001","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pcad.2010.04.001","article-title":"The Framingham Heart Study's impact on global risk assessment","volume":"53","author":"Bitton","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0025","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S2213-8587(17)30221-8","article-title":"Development and validation of risk equations for complications of type 2 diabetes (RECODe) using individual participant data from randomised trials","volume":"5","author":"Basu","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0030","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cmet.2018.08.014","article-title":"The role of advanced glycation end products in aging and metabolic diseases: bridging association and causality","volume":"28","author":"Chaudhuri","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0035","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0040","doi-asserted-by":"crossref","first-page":"39027","DOI":"10.1074\/jbc.M006700200","article-title":"Effect of collagen turnover on the accumulation of advanced glycation end products","volume":"275","author":"Verzijl","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0045","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00125-004-1451-2","article-title":"Simple non-invasive assessment of advanced glycation endproduct accumulation","volume":"47","author":"Meerwaldt","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0050","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1681\/ASN.2005020144","article-title":"Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients","volume":"16","author":"Meerwaldt","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0055","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.2337\/dc05-2173","article-title":"Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes","volume":"29","author":"Lutgers","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0060","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2337\/dc07-1755","article-title":"Skin autofluorescence - a tool to identify type 2 diabetic patients at risk for developing microvascular complications","volume":"31","author":"Gerrits","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0065","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1161\/ATVBAHA.115.305407","article-title":"Skin autofluorescence as a measure of advanced glycation end products deposition predicts 5-year amputation in patients with peripheral artery disease","volume":"35","author":"de Vos","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0070","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/ATVBAHA.113.302731","article-title":"Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease","volume":"34","author":"de Vos","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0075","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12933-016-0448-8","article-title":"Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study","volume":"15","author":"Velayoudom-Cephise","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0080","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00125-018-4769-x","article-title":"Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population","volume":"62","author":"van Waateringe","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0085","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00125-009-1308-9","article-title":"Skin autofluorescence provides additional information to the UK prospective diabetes study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus","volume":"52","author":"Lutgers","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0090","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2215\/CJN.09510913","article-title":"Skin autofluorescence and all-cause mortality in stage 3 CKD","volume":"9","author":"Fraser","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003163","article-title":"The association of skin autofluorescence with cardiovascular events and all-cause mortality in persons with chronic kidney disease stage 3: a prospective cohort study","volume":"17","author":"Shardlow","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2337\/dc06-1391","article-title":"Skin autofluorescence is a strong predictor of cardiac mortality in diabetes","volume":"30","author":"Meerwaldt","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12933-018-0718-8","article-title":"Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study","volume":"17","author":"Blanc-Bisson","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12902-020-00676-4","article-title":"Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes","volume":"21","author":"Boersma","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0115","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.jacc.2008.02.051","article-title":"Erectile dysfunction predicts coronary heart disease in type 2 diabetes","volume":"51","author":"Ma","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0120","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00125-006-0376-3","article-title":"End-stage renal disease risk equations for Hong Kong chinese patients with type 2 diabetes: Hong Kong diabetes registry","volume":"49","author":"Yang","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0125","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1464-5491.1993.tb00083.x","article-title":"Monitoring the targets of the St Vincent Declaration and the implementation of quality management in diabetes care: the DIABCARE initiative. The DIABCARE Monitoring Group of the St Vincent Declaration Steering Committee","volume":"10","author":"Piwernetz","year":"1993","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0130","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0135","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0140","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/sim.3841","article-title":"Dose-response analyses using restricted cubic spline functions in public health research","volume":"29","author":"Desquilbet","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v045.i03","article-title":"MICE: multivariate imputation by chained equations in R","volume":"45","author":"Buuren","year":"2011","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0150","series-title":"Multiple imputation for nonresponse in surveys","volume":"vol 81","author":"Rubin","year":"2004"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0155","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0160","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/dme.12005","article-title":"Skin autofluorescence and risk of micro- and macrovascular complications in patients with type 2 diabetes mellitus-a multi-Centre study","volume":"29","author":"Noordzij","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0165","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.2337\/dc12-0053","article-title":"Skin intrinsic fluorescence is associated with coronary artery disease in individuals with long duration of type 1 diabetes","volume":"35","author":"Conway","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0170","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009833","article-title":"Skin autofluorescence-indicated advanced glycation end products as predictors of cardiovascular and all-cause mortality in high-risk subjects: a systematic review and meta-analysis","volume":"7","author":"Cavero-Redondo","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0175","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1073\/pnas.94.12.6474","article-title":"Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy","volume":"94","author":"Koschinsky","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0180","doi-asserted-by":"crossref","first-page":"13915","DOI":"10.1073\/pnas.94.25.13915","article-title":"Tobacco smoke is a source of toxic reactive glycation products","volume":"94","author":"Cerami","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0185","article-title":"A physically active lifestyle is related to a lower level of skin autofluorescence in a large population with chronic-disease (LifeLines cohort)","author":"Corine van de Zande","year":"2020","journal-title":"J Sport Health Sci"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0190","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ajcn\/nqaa117","article-title":"The association between dietary and skin advanced glycation end products: the Rotterdam study","volume":"112","author":"Chen","year":"2020","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jdiacomp.2021.108015_bb0195","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.2337\/dc12-1077","article-title":"Skin autofluorescence reflects integration of past long-term glycemic control in patients with type 1 diabetes","volume":"36","author":"Sugisawa","year":"2013","journal-title":"Diabetes Care"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872721002245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872721002245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:14:20Z","timestamp":1761005660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872721002245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1056872721002245"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2021.108015","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin autofluorescence is associated with higher risk of cardiovascular events in Chinese adults with type 2 diabetes: A prospective cohort study from the Hong Kong Diabetes Biobank","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2021.108015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108015"}}